يعرض 721 - 740 نتائج من 100,112 نتيجة بحث عن '(( 5 ng decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', وقت الاستعلام: 1.50s تنقيح النتائج
  1. 721

    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  2. 722

    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  3. 723

    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  4. 724

    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  5. 725

    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  6. 726

    Table_1_v2_A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study.docx حسب Bin Liu (5899)

    منشور في 2022
    "…After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.</p>Conclusions<p>A long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. …"
  7. 727
  8. 728
  9. 729

    Image1_Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models.jpg حسب Karthikeyan Selvarasu (14004867)

    منشور في 2022
    "…We also found that the knockdown and knockout (KO) of KIFf5B significantly decreased the tau stability, and overexpression of KIF5B in KIF5B-KO cells significantly increased the expression of phosphorylated and total tau levels. …"
  10. 730
  11. 731
  12. 732
  13. 733
  14. 734
  15. 735

    Inhibition of the <i>Hedgehog</i> pathway leads to decreased ostegenesis <i>in vitro</i>. حسب Emily R. Nelson (247130)

    منشور في 2013
    "…<p>(A–B) qRT-PCR of e13.5 wild-type, CD-1 palate cultures treated with DMEM F12 +/− supplementation with cyclopamine (20 mM) or Shh-N (250 ng/mL) for 2 days. …"
  16. 736
  17. 737

    Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs حسب Olivier Reynard (354756)

    منشور في 2016
    "…In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. …"
  18. 738

    Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis. حسب Swati Biswas (73661)

    منشور في 2013
    "…Both 13C4 and 1D11 was used at a concentration of 25 µg/ml. TGFβ as used at a concentration of 5 ng/ml. …"
  19. 739
  20. 740